Algiax Pharmaceuticals

Algiax Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative treatments for chronic neuropathic pain, particularly through GABAA receptor modulators

algiax.com

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical development

Model

01Company Overview

Algiax Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative treatments for chronic neuropathic pain, particularly through GABAA receptor modulators.

02Backed By1 investor

OOccident→

03Recent Activity

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

FROM Occident

Algiax presented promising Phase 2 results for lead compound AP-325 in peripheral postoperative neuropathic pain, showing reduced side effects.

MILESTONE·occident.group

FEB 4, 2025

04Similar Companies

NP

Noema Pharma

Biotech & Life Sciences

→

LB

Latigo Biotherapeutics

Biotech & Life Sciences

→

SM

Slate Medicines

Biotech & Life Sciences

→

MM

Mimetic Medicine

Biotech & Life Sciences

→

KL

Kezar Life Sciences

Biotech & Life Sciences

→

05Startup DNA

signals

Sectors
Business Model
Technology

Quick Reference

Sector

Biotech & Life Sciences · Healthcare & Digital Health

Website

algiax.com

Visit algiax.com ↗